(Q54459170)

30 May 2018

title

Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma. (English)

1 reference

30 May 2018

author name string

Jeng-Wei Lu

1

1 reference

30 May 2018

Yueh-Min Lin

2

1 reference

30 May 2018

Jan-Gowth Chang

3

1 reference

30 May 2018

Kun-Tu Yeh

4

1 reference

30 May 2018

Rong-Ming Chen

5

1 reference

30 May 2018

Jeffrey J P Tsai

6

1 reference

30 May 2018

Wei-Wen Su

7

1 reference

30 May 2018

Rouh-Mei Hu

8

1 reference

30 May 2018

publication date

5 January 2013

1 reference

30 May 2018

published in

Medical Oncology

1 reference

30 May 2018

volume

30

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

379

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s12032-012-0379-5

exact match

0 references

cites work

G1 events and regulation of cell proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

The retinoblastoma protein pathway and the restriction point

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cell cycle, CDKs and cancer: a changing paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cycling to cancer with cyclin D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Elevated expression of CDK4 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Overexpression of cdk4/cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Requirement for CDK4 kinase function in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin-dependent kinase 4 (CDK4) expression in pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

21 January 2018

Cyclin D and oncogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Nuclear cyclin D1: an oncogenic driver in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Hepatocellular carcinoma: an epidemiologic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Early HCC: diagnosis and molecular markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Abnormal expression of period 1 (PER1) in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Gene expression patterns in human liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Role of cyclin D1 amplification and expression in vulvar carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Expression of Cyclin D1 Is Associated with β-Catenin Expression and Correlates with Good Prognosis in Colorectal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D1, Id1 and EMT in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Cyclin D1 expression is regulated by the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0379-5

Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence

1 reference

12 December 2020

Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation

1 reference

12 December 2020

Cyclin D1 predicts the prognosis of advanced serous ovarian cancer

1 reference

12 December 2020

Molecular genetics of hepatocellular neoplasia.

1 reference

12 December 2020

Cyclin D1 amplification in tongue and cheek squamous cell carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma

1 reference

12 December 2020

Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis

1 reference

12 December 2020

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines

1 reference

12 December 2020

Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma

1 reference

12 December 2020

Is Cyclin D1-CDK4 kinase a bona fide cancer target?

1 reference

12 December 2020

Immunohistochemistry of cyclin D1 in human breast cancer

1 reference

12 December 2020

Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis

1 reference

12 December 2020

Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma

1 reference

12 December 2020

Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines

1 reference

12 December 2020

Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours

1 reference

12 December 2020

Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience

1 reference

12 December 2020

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

12 December 2020

Abnormal expression of JUNB gene in hepatocellular carcinoma

1 reference

12 December 2020

Cyclin D1 overexpression in hepatocellular carcinoma

1 reference

12 December 2020

Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas

1 reference

12 December 2020

Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.

1 reference

12 December 2020

p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas

1 reference

12 December 2020

Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.

1 reference

12 December 2020

A role for Cdk4 in angiogenesis.

1 reference

12 December 2020

10.1007/S12032-012-0379-5

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

23292829

1 reference

30 May 2018